Literature DB >> 16005144

EPHX1 gene polymorphisms and individual susceptibility to lung cancer.

Anu Voho1, Katja Metsola, Sisko Anttila, Olli Impivaara, Jorma Järvisalo, Harri Vainio, Kirsti Husgafvel-Pursiainen, Ari Hirvonen.   

Abstract

We investigated the roles of EPHX1 Tyr113His and His139Arg polymorphisms in lung cancer susceptibility in a Finnish study population comprising of 230 lung cancer cases and a large control group (n=2105). The controls were distributed into five age strata, which enabled us to examine the potential age-related changes in the putative EPHX1 at-risk genotypes in the cancer free population. Although the exon 3 slow activity associated allele (His113) containing genotypes posed a decreased lung cancer risk compared with the homozygous wild-type Tyr113/Tyr113 genotype (OR, 0.68; 95% CI, 0.49-0.94), no association was seen for the EPHX1 phenotypes interpreted from the combined exons 3 and 4 genotype data. Neither was any difference seen in the prevalence of the EPHX1 Tyr113His genotypes or interpreted EPHX1 phenotypes in the different age groups.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16005144     DOI: 10.1016/j.canlet.2005.05.029

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  8 in total

1.  Correlating observed odds ratios from lung cancer case-control studies to SNP functional scores predicted by bioinformatic tools.

Authors:  Yong Zhu; Aaron Hoffman; Xifeng Wu; Heping Zhang; Yawei Zhang; Derek Leaderer; Tongzhang Zheng
Journal:  Mutat Res       Date:  2007-11-26       Impact factor: 2.433

2.  EPHX1 A139G polymorphism and lung cancer risk: a meta-analysis.

Authors:  Hong Liu; Hai-Yan Li; Hong-Jie Chen; Yong-Jie Huang; Shao Zhang; Jing Wang
Journal:  Tumour Biol       Date:  2012-10-09

Review 3.  Association between microsomal epoxide hydrolase 1 T113C polymorphism and susceptibility to lung cancer.

Authors:  Siwen Wang; Jie Zhu; Ruxin Zhang; Siyang Wang; Zongheng Gu
Journal:  Tumour Biol       Date:  2013-02-03

4.  Putative EPHX1 enzyme activity is related with risk of lung and upper aerodigestive tract cancers: a comprehensive meta-analysis.

Authors:  Xiang Li; Zheng Hu; Xinshun Qu; Jiadong Zhu; Lin Li; Brian Z Ring; Li Su
Journal:  PLoS One       Date:  2011-03-18       Impact factor: 3.240

5.  Polymorphisms associated with the risk of lung cancer in a healthy Mexican Mestizo population: Application of the additive model for cancer.

Authors:  Rebeca Pérez-Morales; Ignacio Méndez-Ramírez; Clementina Castro-Hernández; Ollin C Martínez-Ramírez; María Eugenia Gonsebatt; Julieta Rubio
Journal:  Genet Mol Biol       Date:  2011-10-01       Impact factor: 1.771

Review 6.  An Improved Version of Logistic Bayesian LASSO for Detecting Rare Haplotype-Environment Interactions with Application to Lung Cancer.

Authors:  Yuan Zhang; Swati Biswas
Journal:  Cancer Inform       Date:  2015-02-09

7.  Quantitative assessment of the influence of EPHX1 gene polymorphisms and cancer risk: a meta-analysis with 94,213 subjects.

Authors:  Xiaoqin Yang; Yubing Wang; Guiping Wang
Journal:  J Exp Clin Cancer Res       Date:  2014-09-28

8.  Phase I metabolic genes and risk of lung cancer: multiple polymorphisms and mRNA expression.

Authors:  Melissa Rotunno; Kai Yu; Jay H Lubin; Dario Consonni; Angela C Pesatori; Alisa M Goldstein; Lynn R Goldin; Sholom Wacholder; Robert Welch; Laurie Burdette; Stephen J Chanock; Pier Alberto Bertazzi; Margaret A Tucker; Neil E Caporaso; Nilanjan Chatterjee; Andrew W Bergen; Maria Teresa Landi
Journal:  PLoS One       Date:  2009-05-21       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.